Pancreatic cancer: Advances and challenges

CJ Halbrook, CA Lyssiotis, MP di Magliano, A Maitra - Cell, 2023 - cell.com
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers. Significant
efforts have largely defined major genetic factors driving PDAC pathogenesis and …

Chromosomal instability as a driver of cancer progression

X Chen, AS Agustinus, J Li, M DiBona… - Nature Reviews …, 2024 - nature.com
Chromosomal instability (CIN) refers to an increased propensity of cells to acquire structural
and numerical chromosomal abnormalities during cell division, which contributes to tumour …

Interferon-ε is a tumour suppressor and restricts ovarian cancer

ZRC Marks, NK Campbell, NE Mangan… - Nature, 2023 - nature.com
High-grade serous ovarian cancers have low survival rates because of their late
presentation with extensive peritoneal metastases and frequent chemoresistance, and …

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

Q Lu, D Kou, S Lou, M Ashrafizadeh, AR Aref… - Journal of Hematology & …, 2024 - Springer
Cancer immunotherapy and vaccine development have significantly improved the fight
against cancers. Despite these advancements, challenges remain, particularly in the clinical …

Aneuploidy as a driver of human cancer

E Sdeor, H Okada, R Saad, T Ben-Yishay… - Nature Genetics, 2024 - nature.com
Aneuploidy, an abnormal chromosome composition, is a major contributor to cancer
development and progression and an important determinant of cancer therapeutic …

Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer

H Singh, RB Keller, KS Kapner, J Dilly… - Clinical Cancer …, 2023 - AACR
Abstract Purpose: Approximately 8% to 10% of pancreatic ductal adenocarcinomas (PDAC)
do not harbor mutations in KRAS. Understanding the unique molecular and clinical features …

Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain

S Gan, DG Macalinao, SH Shahoei, L Tian, X **… - Cancer cell, 2024 - cell.com
Brain metastasis, a serious complication of cancer, hinges on the initial survival,
microenvironment adaptation, and outgrowth of disseminated cancer cells. To understand …

Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial

M Pouyiourou, BN Kraft, T Wohlfromm, M Stahl… - Nature …, 2023 - nature.com
Cancer of unknown primary has a dismal prognosis, especially following failure of platinum-
based chemotherapy. 10-20% of patients have a high tumor mutational burden (TMB), which …

Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways

L Spain, A Coulton, I Lobon, A Rowan, D Schnidrig… - Cancer discovery, 2023 - AACR
Understanding the evolutionary pathways to metastasis and resistance to immune-
checkpoint inhibitors (ICI) in melanoma is critical for improving outcomes. Here, we present …

Nivolumab for patients with high-risk oral leukoplakia: A nonrandomized controlled trial

GJ Hanna, A Villa, SP Nandi, R Shi, A ONeill… - JAMA …, 2024 - jamanetwork.com
Importance Proliferative verrucous leukoplakia (PVL) is an aggressive oral precancerous
disease characterized by a high risk of transformation to invasive oral squamous cell …